Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system. The company announced 2Q financial results that show a clinical stage company with good cash and a solid balance sheet. The company is making great progress in its Gemini program.
